Salarius Pharmaceuticals Adjourns 2025 Annual Meeting of Stockholders

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) convened its 2025 Annual Meeting of Stockholders on December 19, 2025, but the meeting was adjourned due to an insufficient number of shares present or represented by proxy to constitute a quorum. The required quorum is 34% of outstanding shares. Proxies submitted represented approximately 30% of the outstanding shares as of the record date. The meeting will reconvene virtually on December 31, 2025, at 10:00 am Central Time. No changes have been made to the proposals. The record date remains October 24, 2025. Stockholders are encouraged to vote via the internet, phone, or by contacting the company's proxy solicitor.